- 40 Principal Investigators
- 23 Research Sites
- 29 Publications
Latest News
- 01.15.25 Drug discovery efforts are producing promising antiviral compounds and academic innovation is the key More
- 12.12.24 Antiviral Researchers at University of North Carolina at Chapel Hill READDI Speed Drug Discovery with CDD Vault More
- 11.26.24 Novel oral drug in READDI-AC halts SARS-CoV-2 replication and improves outcomes in preclinical studies More
The devastating effects of the SARS-CoV-2 pandemic illustrates the critical need for new antiviral treatments – the collaborative coalition of READDI-AC is focused on addressing this need head-on.”